All-Cause Mortality Benefit of Revascularization vs. Medical Therapy in Patients Without Known CAD Undergoing Coronary CTA

Presenter: James K. Min

REGISTER for free or LOG IN to view this content

All-Cause Mortality Benefit of Revascularization vs. Medical Therapy in Patients Without Known CAD Undergoing Coronary CTA

We Recommend